Kewaunee Scientific (KEQU) Current Deferred Revenue (2011 - 2026)

Kewaunee Scientific's Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 47.68% year-over-year to $4.1 million; the TTM figure through Jan 2026 stood at $4.1 million (down 47.68% YoY), while the FY2025 annual figure was $6.1 million, up 38.84% from the prior year.
• Current Deferred Revenue was $4.1 million for Q1 2026 at Kewaunee Scientific, down from $4.3 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $14.1 million in Q3 2022 to a low of $3.1 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $6.3 million across 5 years, with a median of $5.0 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue soared 452.49% in 2022, then slumped 56.84% in 2023.
• A 5-year view of Current Deferred Revenue shows it stood at $11.4 million in 2022, then plunged by 56.84% to $4.9 million in 2023, then gained by 26.83% to $6.2 million in 2024, then sank by 30.41% to $4.3 million in 2025, then retreated by 6.33% to $4.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $4.1 million (Q1 2026), $4.3 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.